Sterne Agee Sees Mixed Factors For Teva Pharmaceutical Industries Ltd. By: Benzinga via Benzinga May 02, 2014 at 09:39 AM EDT In a report published Friday, Sterne Agee analyst Shibani Malhotra reiterated a Neutral rating and $53.00 price target on Teva ... Read More >> Related Stocks: Teva Pharmaceutical Industries ADR